Outstanding performance and convenience in this easy to use kit

August 18, 2010- State College, PA INDIGO Biosciences, The Nuclear Receptor Company, announces the addition of another product to its growing line of INDIGO Nuclear Receptor Assay Kits. The INDIGO TRα Assay Kit is a robust, convenient screening solution for researchers in toxicology and drug discovery and development research.

Human Thyroid Hormone Receptor (TRα) is a nuclear hormone receptor that is important in the mediation of the biological activities of the thyroid hormone. The INDIGO TRα Assay Kits are a valuable asset for researchers studying the metabolic effects of various thyroid activities. INDIGO’s Chief Technology Officer, Dr. Bruce Sherf, says "In addition to their overall convenience and ease of use, INDIGO's new Family of human TR cell-based reporter assay systems provide performance metrics such as S/B , Z', and assay reproducibility that, we believe, are unsurpassed. These products will provide immediate benefit to anyone intending to conduct functional screens against human TRa."

The INDIGO TRα Assay Kits are essentially a lab-in-a-box that enables researchers to go from freezer to data in 24 hours using four easy steps: Thaw, Feed, Dose, Read. INDIGO Nuclear Receptor Assay Kits do not require cell counting or washing steps. The INDIGO TRα Assay Kits are highly reliable. They feature unsurpassed Z’ scores and signal-to-noise ratios. INDIGO Biosciences’ proprietary cryopreservation process, CryoMite, has 95% cell viability post-thaw and enables INDIGO Nuclear Receptor Assay Kits to be shipped overnight, making them ready to use when the researcher is ready to test.